针对轻度认知障碍的不同针和催化疗法:一个网络元分析
Na Yi1, Dajiang Xing2, Jingru Xie3
1School of Acupuncture and Massage, Liaoning University of Traditional Chinese Medicine, Shenyang Liaoning 110847, China.
Archives of gerontology and geriatrics
|January 18, 2024
概括
针点按压,单独或与耳部点粘合,显示了改善轻度认知障碍 (MCI) 患者的认知功能. 这种针方法可能是对MCI最有效的治疗方法.
科学领域:
- 综合医学是一个整体的医学.
- 神经科学是一个神经科学.
- 老年学是一门学科.
背景情况:
- 轻度认知障碍 (MCI) 是痴呆症的一个重要风险因素.
- 有效的干预措施来改善MCI患者的认知功能至关重要.
- 针和是具有潜在神经保护作用的传统疗法.
研究的目的:
- 评估各种针和催眠疗法的疗效,以提高MCI患者的认知功能.
- 为了确定MCI治疗的最佳针和摩克西布施疗方法.
- 为未来的随机对照试验和MCI管理的临床实践提供信息.
主要方法:
- 在多个数据库 (PubMed,Embase,Cochrane图书馆等) 进行了全面的文献搜索. ) 的情况.
- 符合条件的随机对照试验 (RCT) 用Cochrane工具评估了偏差风险.
- 使用R软件进行贝叶斯网络元分析,以比较治疗有效性.
主要成果:
- 该分析包括46个RCT,涉及3641名参与者.
- 对于MMSE得分,针按压 + 认知训练 + 耳部点贴,按摩 + 西医,电针 + 西医是前三项干预措施.
- 对于MoCA分数,针点按压+认知训练,认知训练+头皮针,认知训练+摩克西布斯排名最高.
结论:
- 针点按压,单独或与耳朵点粘合相结合,似乎是一种非常有效的针干预措施,用于改善MCI的认知功能.
- 这些发现表明了特定的针策略,需要对MCI治疗进行进一步的研究.
更多相关视频
05:54Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
Published on: May 10, 2024
1.4K
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
1.5K
相关概念视频
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
126
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
126
01:22Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195